The impact of 18F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 652-660

  Yasuda, Takushi ^a   Higuchi, Ichiro ^a   Yano, Masahiko ^a   Miyata, Hiroshi ^a   Yamasaki, Makoto ^a   Takiguchi, Shuji ^a   Fujiwara, Yoshiyuki ^a   Hatazawa, Jun ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; AGED; CANCER GRADING; CANCER STAGING; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THORAX TUMOR; TUMOR RECURRENCE;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; THORACIC NEOPLASMS;

EID: 84856678779     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1928-4     Document Type: Article

References (32)

1. G Chen Z Wang X Liu F Liu 2007 Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy World J Surg. 31 1107 1114 17426905
2. SM Dresner SM Griffin 2000 Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy Br J Surg 87 1426 1433 11044172 10.1046/j.1365-2168.2000.01541.x 1:STN:280:DC%2BD3crgtVGrsg%3D%3D
3. Malthaner RA, Wong RK, Rumble RB, Zuraw L, Members of the gastrointestinal cancer disease site group of cancer care ontario's program in evidence-based care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med. 2004;24:35. Available at: http://www.biomedcentral.com/1741-7015/2/35.
4. Australasian gastro-intestinal trial group V Gebski B Burmeister BM Smithers K Foo J Zalcberg J Simes 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol. 8 226 234 17329193 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D
5. D Cunningham WH Allum SP Stenning JN Thompson CJ Van de Velde M Nicolson, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20 16822992 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D
6. C Mariette G Piessen N Briez JP Triboulet 2008 The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 365 371 18216546 10.1097/SLA.0b013e31815aaadf
7. N Rizk E Venkatraman B Park R Flores MS Bains V Rusch 2006 The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American joint committee on cancer staging system J Thorac Cardiovasc Surg 132 1374 1381 17140960 10.1016/j.jtcvs.2006.07. 039
8. C Kunisaki H Makino J Kimura T Oshima S Fujii R Takagawa, et al. 2010 Impact of lymph-node metastasis site in patients with thoracic esophageal cancer J Surg Oncol 101 36 42 19921710 10.1002/jso.21425
9. M Wilson EL Rosato KA Chojnacki I Chervoneva JC Kairys HE Cohn, et al. 2008 Prognostic significance of lymph node metastases and ratio in esophageal cancer J Surg Res. 146 11 15 18028955 10.1016/j.jss.2007.07.028
10. EPM van Vliet MH Heijenbrok-Kal MGM Hunink EJ Kuipers PD Sierserma 2008 Staging investigations for oesophageal cancer: a meta-analysis Br J Cancer. 98 547 557 18212745 10.1038/sj.bjc.6604200
11. M Barthet 2007 Endoscopic ultrasound teaching and learning Minerva Med. 98 247 251 17921934 1:STN:280:DC%2BD2sngtVWqsw%3D%3D
12. T Lerut P Flamen N Ectors E Van Cutsem M Peeters M Hiele, et al. 2000 Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction. A prospective study based on primary surgery with extensive lymphadenectomy Ann Surg. 232 743 752 11088069 10.1097/00000658-200012000-00003 1:STN:280:DC%2BD3M%2FltVyntA%3D%3D
13. P Flamen A Lerut E van Cutsem W De Wever M Peeters S Stroobants, et al. 2000 Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol. 18 3202 3210 10986052 1:STN:280:DC%2BD3cvotlentw%3D%3D
14. T Komori Y Doki T Kabuto O Ishikawa M Hiratsuka Y Sasaki, et al. 2003 Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers J Surg Oncol. 82 19 27 12501165 10.1002/jso.10184
15. 18F uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma J Thorac Cardiovasc Surg. 136 205 212 18603077 10.1016/j.jtcvs.2008.02.016
16. H Kato H Kuwano M Nakajima T Miyazaki M Yoshikawa H Ojima, et al. 2002 Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer. 94 921 928 11920459 10.1002/cncr.10330
17. Sobin LH, Wittekind C. eds. TNM Classification of Malignant Tumors. 6th ed. New York: Wiley, 2002.
18. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al., eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
19. H Fukunaga M Sekimoto M Tatsumi M Ikenaga M Ohue I Seshimo, et al. 2002 Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer Int J Oncol. 20 691 695 11894111
20. 18F]fluorodeoxyglucose in the pretreatment evaluation of patients with oesophageal cancer Nucl Med Commun. 24 963 970 12960595 10.1097/00006231-200309000-00004 1:STN:280: DC%2BD3svitFWjsg%3D%3D
21. H Shiozaki M Yano T Tsujinaka M Inoue S Tamura Y Doki, et al. 2001 Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer Dis Esophagus. 14 191 196 11869318 10.1046/j.1442-2050.2001.00206.x 1:STN:280:DC%2BD387jtl2mtA%3D%3D
22. RJ Cerfolio AS Bryant 2006 Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival Ann Thorac Surg. 82 391 395 16863735 10.1016/j.athoracsur.2006.03.045
23. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. Chicago: Springer, 2010.
24. Rice TW, Rusch VW, Blackstone EH. 2009 AJCC/UICC staging of esophageal cancer. In: Shields TW, Locicero J, Reed CE, Feins RH, eds. General Thoracic Surgery. 7th ed. Vol 2. Amsterdam: Wolters Kluwer, 2009:2013-5.
25. HL Zhang LQ Chen RL Liu YT Shi M He XL Meng, et al. 2010 The number of lymph node metastases influences survival and international union against cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma Dis Esophagus. 23 53 58 19392846 10.1111/j.1442-2050.2009.00971.x 1:CAS:528:DC%2BC3MXivFaltg%3D%3D
26. PK Hsu YC Wu TY Chou CS Huang WH Hsu 2010 Comparison of the 6th and 7th editions of the American joint committee on cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma Ann Thorac Surg. 89 1024 1031 20338302 10.1016/j.athoracsur.2010.01.017
27. World Esophageal Cancer Collaboration TW Rice VW Rusch H Ishwaran EH Blackstone 2010 Cancer of the esophagus and esophagogastric junction. Data-driven staging for the seventh edition of American joint committee on cancer/International union against cancer staging manuals Cancer 116 3763 3773 20564099 10.1002/cncr.25146
28. 18F-FDG in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications J Nucl Med. 45 1843 1850 15534053
29. 18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer Cancer. 115 3196 3203 19472406 10.1002/cncr.24399
30. B Sepesi DP Raymond M Polomsky TJ Watson VR Litle CE Jones, et al. 2009 Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer J Gastrointest Surg. 13 2121 2127 19795177 10.1007/s11605-009-1038-9
31. J Shenfine AP Barbour D Wong J Thomas I Martin DC Gotley, et al. 2009 Prognostic value of maximum standardized uptake values from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone Dis Esophagus. 22 668 675 19222534 10.1111/j.1442-2050. 2009.00941.x 1:STN:280:DC%2BD1Mfjt1Cktw%3D%3D
32. Malthaner R, Collin S, Fenlon D, Rhodes S. Preoperative chemotherapy for resectable thoracic esophageal cancer (Review). Cochrane Database Syst Rev. 2006; 3: Art. No.:CD001556. doi: 10.1002/14651858.CD001556.pub2.